College of Nursing, Helene Fuld Health Trust National Institute for Evidence-based Practice in Nursing and Healthcare, The Ohio State University, Columbus, OH 43210, USA.
UCHealth Occupational Medicine Clinic, 13445 Voyager Pkwy, Colorado Springs, CO 80921, USA.
Med Clin North Am. 2022 Sep;106(5):881-898. doi: 10.1016/j.mcna.2022.03.004.
The popularity of and market for natural medicines (herbal remedies, dietary supplements, and vitamins) is accelerating. At the same time, evidence for their effectiveness (both in general and for specific conditions) and safety remains poor in many instances. Independent evaluations have identified products that are poorly manufactured, contaminated, or mislabeled. We examine data on cannabidiol (CBD) to exemplify these problems. Yet consumers often are unaware of these concerns and problems and continue to believe that "natural" means "safe." The current US regulatory framework founded in the 1994 Dietary Supplement Health and Education Act (DSHEA) does not adequately protect the health of US consumers and urgently needs to be revised. At the same time, clinicians should update themselves regularly with the best available evidence on the natural medications most relevant to their areas of practice. We recommend some evidence-based resources that will help clinicians and their patients remain current in this area.
天然药物(草药、膳食补充剂和维生素)的普及和市场正在加速。与此同时,它们的有效性(总体上和针对特定情况)和安全性在许多情况下仍然很差。独立评估已经确定了一些制造不良、污染或标签错误的产品。我们以大麻二酚 (CBD) 为例来探讨这些问题。然而,消费者往往没有意识到这些问题,并且仍然认为“天然”意味着“安全”。目前基于 1994 年《膳食补充剂健康与教育法案》(DSHEA)的美国监管框架没有充分保护美国消费者的健康,迫切需要修订。同时,临床医生应该定期使用与他们实践领域最相关的天然药物的最佳可用证据来更新自己。我们推荐一些循证资源,以帮助临床医生及其患者在这一领域保持最新信息。